Antibody Treatment Approved for Emergency Use Against Early COVID-19
Treatment approved for people newly infected with COVID-19 who are at high risk for progressing to severe disease
Many at Risk for Severe COVID-19 Have Essential Jobs
Up to 74 million U.S. adults at risk for severe infection are essential workers or live with one
Tool Could Optimize Antibiotic Prescribing for UTI
Authors say decision support tool could help reduce antibiotic resistance by cutting use of broad-spectrum antibiotics
Preexisting Tinnitus May Be Exacerbated by COVID-19
Tinnitus exacerbated for those self-isolating, feeling lonely, sleeping poorly, exercising less
Pfizer COVID-19 Vaccine Reaches 90 Percent Effectiveness in Early Analysis
Vaccine requires two doses, given three weeks apart
Cabotegravir Injection Can Protect Women From HIV for Two Months
Experimental drug found to be 89 percent more effective at preventing HIV infection than Truvada pills
Medicare Outpatient Premium to Rise
Monthly premium for outpatient care will rise by $3.90 next year
About One in Five Children Have Vaccine-Hesitant Parent
Influenza vaccine coverage 26 percent lower for children of parents reported to be hesitant about childhood shots
Hospital Stays After Delivery Shorter With Pandemic Protocols
Despite shorter stays, no differences seen in maternal or newborn adverse outcomes
